Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bang-Nian Shen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|April 24, 2020
Promising Strategies for Overcoming BRAF Inhibitor Resistance Based on Known Resistance MechanismsQing-Shan Li, Bang-Nian Shen, Hua-Jian Xu, et al.
Current Medicinal Chemistry|March 7, 2020
Discovery of Anticancer Agents from 2-Pyrazoline-Based CompoundsQing-Shan Li, Bang-Nian Shen, Zhen Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 19, 2019
Synthesis and <i>in vitro</i> and <i>in vivo</i> anti-inflammatory activity of novel 4-ferrocenylchroman-2-one derivativesWei-Yun Guo, Liu-Zeng Chen, Bang-Nian Shen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Anti-Cancer Agents in Medicinal Chemistry|April 24, 2020
Promising Strategies for Overcoming BRAF Inhibitor Resistance Based on Known Resistance MechanismsQing-Shan Li, Bang-Nian Shen, Hua-Jian Xu, et al.
Current Medicinal Chemistry|March 7, 2020
Discovery of Anticancer Agents from 2-Pyrazoline-Based CompoundsQing-Shan Li, Bang-Nian Shen, Zhen Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 19, 2019
Synthesis and <i>in vitro</i> and <i>in vivo</i> anti-inflammatory activity of novel 4-ferrocenylchroman-2-one derivativesWei-Yun Guo, Liu-Zeng Chen, Bang-Nian Shen, et al.
Pageof 1